Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Immunrise Biocontrol

Active#30 worldwide · Biological inputs

Develops a biofungicide based on the microalga Amphidinium carterae to protect vines, field crops and vegetables against fungal diseases such as mildew, including as a seed treatment.

HQFrance
Last roundFunding round · Aug 2022

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Biological inputs · worldwideTop 32#30Edition 0 · Oct 202612 Feb 2027
Rank historyOct 2026 · #30 Biological inputsFirst edition: no movements yet.

Estimated valuation

AI · Biological inputs ranking (worldwide)
≈ USD 26MUSD 18–40M · Tens of M$
Anchor
Last known equity round: Funding round · USD 5.1M · Aug 2022

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestors
Aug 2022Funding roundUSD 5.1MEquityBaron Philippe de Rothschild group, De Sangosse

EUR 5M.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Immunrise Biocontrol as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $26MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in biological inputs

Full biological inputs ranking →

Investors in Immunrise Biocontrol: Baron Philippe de Rothschild group · De Sangosse

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.